Sensai
Sensai
AI Stock Dissection
AI Stock Dissection
EMAMILTD
Mr. Harsha Vardhan Agarwal B.Com. · Kolkata, India
₹407.85
▲+0.18%EMAMI is trading near its 52-week low despite strong profitability metrics, potentially reflecting concerns over revenue growth and high valuation multiples.
Exchange
NSI
Currency
INR
Day range
₹406.40 – ₹414.80
52-week range
₹376.40 – ₹634.20
Sector
Consumer Defensive
Industry
Household & Personal Products
AI investment rating
AI analysis65% confidence
The stock appears moderately overvalued at current levels given its P/E of 22.98 and negative revenue growth, trading near the lower end of its 52-week range.
35.7% below the 1-year high · trend down
Hedge-fund memo
Today
The stock is marginally up today, trading near its intraday low within a narrow range.
This week
The stock has shown slight volatility this week but remains under pressure from its yearly highs.
This month
The stock has declined significantly over the past month, reflecting broader market concerns and company-specific challenges.
Bull thesis
Bear thesis
News & sentiment
Neutral
2 headlines · 2 outlets · 7d
Tone · daily average
Smart money
Named holders aren't published for this listing (common for Indian stocks). The split at left is live.
Financial health
Profitability
Growth
Balance sheet
Financial statements
Earnings intelligence
Beat estimates in 4 of 4 recent quarters (EPS actual vs. consensus).
3.6718 vs 3.56667
2.95% surprise
7.5353 vs 6.8675
9.72% surprise
3.9217 vs 3.9
0.56% surprise
Competitive landscape
| Company | Market cap | P/E | ROE | Op. margin | Rev. growth |
|---|---|---|---|---|---|
| EMAMILTD | 178.03B | 22.98 | 27.61% | 15.61% | -3.90% |
| GODREJCP | 1.10T | 58.94 | 15.10% | 21.98% | 11.20% |
| MARICO | 1.14T | 64.61 | 41.39% |
Technical intelligence
Volume
RSI (14) · 70 overbought / 30 oversold
MACD (12,26,9) · MACD vs signal
Candlesticks, volume, RSI and MACD from 500sessions of real Yahoo daily data. Moving averages use full history, so they're accurate at the left edge. Support / resistance are the 52-week low / high. Educational — technical signals are not buy or sell calls.
Risk intelligence
Declining revenue growth
Mitigation: Product innovation and market expansion initiatives
High valuation multiple
Mitigation: Demonstrating consistent growth to justify the multiple
Increased competition in personal care sector
Mitigation: Strengthening brand differentiation and distribution network
Business intelligence
Competitive moat
Strong brand recognition and extensive distribution network provide a competitive moat in the Indian personal care market.
Supply chain
Upstream (inputs / suppliers)
↓
Downstream (customers / markets)
M&A / strategic moves
Catalyst calendar
Successful launch of new products in health and wellness segment
Improvement in rural market penetration
Thesis builder
Bull case
The stock could rebound if revenue growth improves and the company successfully executes its expansion strategy.
Base case
The stock may trade in a range as the company maintains its strong brand presence but faces growth challenges.
Bear case
Further decline could occur if revenue growth continues to deteriorate and the P/E multiple contracts.
Time horizon
12-18 months
Est. CAGR
5-8%
Entry (qual.)
Consider accumulating if the stock falls below 350 INR with visible signs of revenue recovery
Exit (qual.)
Consider taking profits above 550 INR if growth momentum improves significantly
Overall conviction 65%
Knowledge graph
Executives & sector are live; peers are clickable → their dissection. Institutional holders shown where the exchange publishes them.
Portfolio impact
Enter tickers + weights, then see how EMAMILTD fits.
Scenario simulator
Simulate a macro shock and see the illustrative impact:
Tailwind for tech & enablers.
Illustrative impact
Medium prob.Directional illustration only — not modelled on this company's actuals. A real simulator needs company financials.
Explain like…
Re-explain EMAMILTD for a different audience:
Pick a persona to get a tailored explanation.
Sensai publishes educational market commentary, not investment advice. We are not SEBI-registered investment advisers or research analysts, and nothing here is a recommendation to buy, sell, or hold any security.
Live prices, index levels, and other market data are pulled from third-party feeds, may be delayed, and can be inaccurate or unavailable. Do not rely on them for trading decisions.
Investing in equities carries risk, including the loss of principal. Always do your own research and consider consulting a SEBI-registered adviser before making any investment decision.
Hidden risks
Hidden opportunities
Watch next
Hold with caution, waiting for clearer signs of revenue growth recovery before adding positions.
scanx.trade·1d ago·standard corporate procedure
TradingView·5d ago·neutral information
Real press coverage from the last 7 days, scored by AI for tone — click any headline for the source. This is news sentiment, not social: X / Reddit / Telegram scoring needs a paid social provider. Educational only.
Annual income statement, oldest → newest. Live via Yahoo.
4.2193 vs 3.77
11.92% surprise
| 13.98% |
| 22.10% |
| COLPAL | 567.04B | 42.02 | — | 27.68% | 11.80% |
Peers via Yahoo's similarity graph, same-sector first; fundamentals live. Ask the AI copilot below for a qualitative head-to-head.
Support (day/52w low)
₹406.40
Resistance (day/52w high)
₹414.80
Volume
4,40,300
Trend
down
RSI (14)
46
MACD
bearish
MA cross
death
50-day MA
₹405.16
200-day MA
₹462.89
vs 200-DMA
-11.9%
RSI/MACD computed from 6 months of daily closes; moving averages from Yahoo. Options positioning still needs an options feed.